Back to Archived Journals » Biosimilars » Volume 6 » default

Biosimilars ceased publishing in October 2016. All new submissions can be made to Biologics: Targets and Therapy. All articles that have been published in Biosimilars will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Archive: Volume 6, 2016

Physicochemical and biological comparison of the first Brazilian biosimilar filgrastim with its reference product

Mantovani M, Caruso CS, Facchini FDA, Pascon R, Cagnacci PRV, de Magalhães VD

Biosimilars 2016, 6:45-60

Published Date: 30 August 2016

Adalimumab: a review of the reference product and biosimilars

Azevedo VF, Troiano LDC, Galli NB, Kleinfelder A, Catolino NM, Martins PCU

Biosimilars 2016, 6:29-44

Published Date: 26 July 2016

Tools for the analysis and characterization of therapeutic protein species

Fuh MM, Steffen P, Schlüter H

Biosimilars 2016, 6:17-24

Published Date: 5 May 2016

Considerations in biosimilar insulin device development

Fry AR, Krentz AJ, Hompesch M

Biosimilars 2016, 6:9-15

Published Date: 16 February 2016

Development, safety, and efficacy of biosimilar adalimumab: the data so far

Gabbani T, Deiana S, Bagnoli S, Annese V

Biosimilars 2016, 6:1-7

Published Date: 29 January 2016